Canada markets closed

Astellas Pharma Inc (YPH.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
9.10-0.16 (-1.75%)
At close: 08:05AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
Cash flows from operating activities
Net Income
17,045,000
17,045,000
98,714,000
124,086,000
120,589,000
Depreciation & amortization
157,840,000
157,840,000
105,738,000
79,684,000
72,652,000
Change in working capital
-86,518,000
-86,518,000
-24,209,000
5,956,000
-31,726,000
Inventory
-60,036,000
-60,036,000
-7,086,000
24,058,000
-2,318,000
Other working capital
89,978,000
89,978,000
239,226,000
180,996,000
229,402,000
Other non-cash items
35,365,000
35,365,000
98,857,000
-17,839,000
38,116,000
Net cash provided by operating activites
172,475,000
172,475,000
327,767,000
257,444,000
306,843,000
Cash flows from investing activities
Investments in property, plant and equipment
-82,497,000
-82,497,000
-88,541,000
-76,448,000
-77,441,000
Acquisitions, net
-784,974,000
-784,974,000
0
-670,000
-14,916,000
Sales/Maturities of investments
0
0
12,624,000
5,576,000
-
Other investing activites
1,816,000
1,816,000
-13,353,000
-15,868,000
2,595,000
Net cash used for investing activites
-845,802,000
-845,802,000
-84,500,000
-62,413,000
-81,894,000
Net change in cash
-41,153,000
-41,153,000
60,854,000
-10,143,000
7,737,000
Cash at beginning of period
376,840,000
376,840,000
315,986,000
326,128,000
318,391,000
Cash at end of period
335,687,000
335,687,000
376,840,000
315,986,000
326,128,000
Free Cash Flow
Operating Cash Flow
172,475,000
172,475,000
327,767,000
257,444,000
306,843,000
Capital Expenditure
-82,497,000
-82,497,000
-88,541,000
-76,448,000
-77,441,000
Free Cash Flow
89,978,000
89,978,000
239,226,000
180,996,000
229,402,000